Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Repurposing ibuprofen to control Staphylococcus aureus biofilms
Publication

Publications

Repurposing ibuprofen to control Staphylococcus aureus biofilms

Title
Repurposing ibuprofen to control Staphylococcus aureus biofilms
Type
Article in International Scientific Journal
Year
2019
Authors
Isabel Maria Oliveira
(Author)
Other
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications Without AUTHENTICUS Without ORCID
Anabela Borges
(Author)
FEUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Fernanda Borges
(Author)
FCUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page Without ORCID
Manuel Simões
(Author)
FEUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Journal
Vol. 166
Pages: 197-205
ISSN: 0223-5234
Publisher: Elsevier
Indexing
Other information
Authenticus ID: P-00Q-6PC
Abstract (EN): Drug repurposing arises as an interesting alternative to overcome the limited efficacy of current available antibiotics by reducing time, cost and risk associated with drug innovation. In this study, the activity of ibuprofen, a non-steroidal anti-inflammatory drug (NSAID), was evaluated on the control of preestablished adhered cells (2 h) and 24 h old biofilms of Staphylococcus aureus. Bacterial adhesion was performed by S. aureus CECT 976, while biofilm formation was also performed by the antibiotic-resistant strains: SA1199B, RN4220 and XU212. The treatment with ibuprofen promoted metabolic reductions up to 80% and total loss of culturability of adhered cells and 24 h old biofilms. Ibuprofen demonstrated moderate efficacy to remove biofilms of S. aureus CECT 976 (removal <= 40%), but did not display removal action against the antibiotic-resistant strains. Antibacterial activity (inhibitory and bactericidal) and mode of action of ibuprofen were also assessed using different bacterial physiological indices. Minimum inhibitory and bactericidal concentrations of the four S. aureus strains ranged between 500 and 2000 mg L-1 and 1400 - >2000 mg L-1, respectively. After S. aureus CECT 976 incubation with ibuprofen, cell permeation to propidium iodide, release of intracellular potassium and changes on cell surface hydrophobicity were observed. The overall results, demonstrate that ibuprofen can control S. aureus planktonic and sessile growth, with strong destabilizing and disrupting action on the cytoplasmic membrane.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 9
Documents
We could not find any documents associated to the publication with allowed access.
Related Publications

Of the same journal

Xanthenes in Medicinal Chemistry - Synthetic strategies and biological activities (2021)
Another Publication in an International Scientific Journal
Maia, M; Resende, DISP; Duraes, F; Pinto, MMM; Emilia Sousa
Tryptophan derived natural marine alkaloids and synthetic derivatives as promising antimicrobial agents (2021)
Another Publication in an International Scientific Journal
Almeida, MC; Resende, DISP; da Costa, PM; Pinto, MMM; Emilia Sousa
Quinoxaline, its derivatives and applications: A State of the Art review (2015)
Another Publication in an International Scientific Journal
Pereira, JA; Pessoa, AM; Natalia N D S Cordeiro; Fernandes, R; Prudencio, C; Noronha, JP; Vieira, M
Diarylpentanoids with antitumor activity: A critical review of structure-activity relationship studies (2020)
Another Publication in an International Scientific Journal
Moreira, J; Lucilia Saraiva; Pinto, MM; Honorina Cidade

See all (82)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-07-15 at 16:27:08 | Privacy Policy | Personal Data Protection Policy | Whistleblowing